BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38582070)

  • 1. Apolipoprotein E and Alzheimer's disease pathology in African American older adults.
    Royse SK; Snitz BE; Hill AV; Reese AC; Roush RE; Kamboh MI; Bertolet M; Saeed A; Lopresti BJ; Villemagne VL; Lopez OL; Reis SE; Becker JT; Cohen AD
    Neurobiol Aging; 2024 Jul; 139():11-19. PubMed ID: 38582070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOE effects on regional tau in preclinical Alzheimer's disease.
    Young CB; Johns E; Kennedy G; Belloy ME; Insel PS; Greicius MD; Sperling RA; Johnson KA; Poston KL; Mormino EC; ;
    Mol Neurodegener; 2023 Jan; 18(1):1. PubMed ID: 36597122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia.
    Salvadó G; Grothe MJ; Groot C; Moscoso A; Schöll M; Gispert JD; Ossenkoppele R;
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2212-2224. PubMed ID: 33521872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE interacts with tau PET to influence memory independently of amyloid PET in older adults without dementia.
    Weigand AJ; Thomas KR; Bangen KJ; Eglit GML; Delano-Wood L; Gilbert PE; Brickman AM; Bondi MW;
    Alzheimers Dement; 2021 Jan; 17(1):61-69. PubMed ID: 32886451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of APOE gene with longitudinal changes of CSF amyloid beta and tau levels in Alzheimer's disease: racial differences.
    Xu C; Xiao D; Su BB; Saveron JM; Gamez D; Navia RO; Wang N; Roy U; Adjeroh DA; Wang K;
    Neurol Sci; 2024 Mar; 45(3):1041-1050. PubMed ID: 37759100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer's disease.
    Baek MS; Cho H; Lee HS; Lee JH; Ryu YH; Lyoo CH
    Alzheimers Res Ther; 2020 Oct; 12(1):140. PubMed ID: 33129364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of sex and APOE ε4 with brain tau deposition and atrophy in older adults with Alzheimer's disease.
    Yan S; Zheng C; Paranjpe MD; Li J; Benzinger TLS; Lu J; Zhou Y
    Theranostics; 2020; 10(23):10563-10572. PubMed ID: 32929366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults.
    Buckley RF; Mormino EC; Rabin JS; Hohman TJ; Landau S; Hanseeuw BJ; Jacobs HIL; Papp KV; Amariglio RE; Properzi MJ; Schultz AP; Kirn D; Scott MR; Hedden T; Farrell M; Price J; Chhatwal J; Rentz DM; Villemagne VL; Johnson KA; Sperling RA
    JAMA Neurol; 2019 May; 76(5):542-551. PubMed ID: 30715078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points.
    Toledo JB; Habes M; Sotiras A; Bjerke M; Fan Y; Weiner MW; Shaw LM; Davatzikos C; Trojanowski JQ;
    J Alzheimers Dis; 2019; 69(3):783-793. PubMed ID: 31127775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOE ε4 is associated with decreased synaptic density in cognitively impaired participants.
    He K; Li B; Wang J; Wang Y; You Z; Chen X; Chen H; Li J; Huang Q; Guo Q; Huang YH; Guan Y; Chen K; Zhao J; Deng Y; Xie F
    Alzheimers Dement; 2024 May; 20(5):3157-3166. PubMed ID: 38477490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOEε4 potentiates amyloid β effects on longitudinal tau pathology.
    Ferrari-Souza JP; Bellaver B; Ferreira PCL; Benedet AL; Povala G; Lussier FZ; Leffa DT; Therriault J; Tissot C; Soares C; Wang YT; Chamoun M; Servaes S; Macedo AC; Vermeiren M; Bezgin G; Kang MS; Stevenson J; Rahmouni N; Pallen V; Poltronetti NM; Cohen A; Lopez OL; Klunk WE; Soucy JP; Gauthier S; Souza DO; Triana-Baltzer G; Saad ZS; Kolb HC; Karikari TK; Villemagne VL; Tudorascu DL; Ashton NJ; Zetterberg H; Blennow K; Zimmer ER; Rosa-Neto P; Pascoal TA
    Nat Aging; 2023 Oct; 3(10):1210-1218. PubMed ID: 37749258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment.
    Insel PS; Hansson O; Mattsson-Carlgren N
    JAMA Neurol; 2021 Feb; 78(2):229-235. PubMed ID: 33044487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain imaging measurements of fibrillar amyloid-β burden, paired helical filament tau burden, and atrophy in cognitively unimpaired persons with two, one, and no copies of the APOE ε4 allele.
    Ghisays V; Goradia DD; Protas H; Bauer RJ; Devadas V; Tariot PN; Lowe VJ; Knopman DS; Petersen RC; Jack CR; Caselli RJ; Su Y; Chen K; Reiman EM
    Alzheimers Dement; 2020 Apr; 16(4):598-609. PubMed ID: 31831374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E ε4 and ε3 alleles associate with cerebrospinal fluid tau and cognition in the presence of amyloid-β in mild cognitive impairment but not in Alzheimer's disease.
    Xing F; Meng T; Therriault J; Luo J; Zhang H;
    J Integr Neurosci; 2021 Jun; 20(2):277-286. PubMed ID: 34258926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of APOE with tau-tangle pathology with and without β-amyloid.
    Farfel JM; Yu L; De Jager PL; Schneider JA; Bennett DA
    Neurobiol Aging; 2016 Jan; 37():19-25. PubMed ID: 26481403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of
    Du J; Li A; Shi D; Chen X; Wang Q; Liu Z; Sun K; Guo T;
    Neurology; 2023 Jul; 101(1):e40-e49. PubMed ID: 37188537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Effects of the Interaction Between the Education and APOE ε4 Allele on Amyloid-beta Retention and Memory Performances in Cognitively Normal Older Adults and Alzheimer's Disease Patients.
    Kang DW; Wang SM; Na HR; Lee CU; Baek IH; Lim HK
    Curr Alzheimer Res; 2020; 17(11):1023-1032. PubMed ID: 33372875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome.
    Bejanin A; Iulita MF; Vilaplana E; Carmona-Iragui M; Benejam B; Videla L; Barroeta I; Fernandez S; Altuna M; Pegueroles J; Montal V; Valldeneu S; Giménez S; González-Ortiz S; Muñoz L; Padilla C; Aranha MR; Estellés T; Illán-Gala I; Belbin O; Camacho V; Wilson LR; Annus T; Osorio RS; Videla S; Lehmann S; Holland AJ; Zetterberg H; Blennow K; Alcolea D; Clarimon J; Zaman SH; Blesa R; Lleó A; Fortea J
    JAMA Neurol; 2021 Aug; 78(8):937-947. PubMed ID: 34228042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.